Registration
Introductory Remarks
K. Pavelic
H. J. Seitz
M. Colic
Nutraceuticals and
Chemoprevention/Cancer Therapies
Chair: H. Mukhtar
(USA)
R. Agarwal, USA
Silymarin and Prostate Cancer: Epigenetic
Events as Molecular Targets
H. Mukhtar, USA
Green Tea in Chemoprevention of Prostate Cancer
U. Wenzel, Germany
Dietary flavone induces selectively
apoptosis in transformed colonocytes
Nutraceuticals and
Cardiovascular Diseases
Chair: R. J. Schaur,
Austria
R. J. Schaur - chairman's
introduction
Vitamin E and Cardiovascular Diseases:
Recent Results and Open Questions
M. Aviram, Israel
Pomegranate juice decreases oxidative
stress, low density lipoprotein atherogenic modifications and atherosclerosis
E. Niki, Japan
The dynamics of therapeutic action
of natural and synthetic antioxidants
Skin Care and Cosmetics
K. Mukhtar, USA
Green Tea and Skin: Anti-inflammatory
and Photoprotective Effects
Molecular
and Cellular Aspects of Small Molecules Therapeutics: Fundamental Science
Chair: P. Stambrook
P. Stambrook, USA
Pathways to mutation: A concern
for genetic toxicology
Pharmacological
Aspects of Nutraceuticals
Chair: P. Stambrook
T. Haqqi, USA
Inhibition of IL-1beta-induced Catabolic
Stimuli In Human Osteoarthritis Chondrocytes By Green Tea Polyphenol Epigallocatechin-3-gallate
Poster Session
Nutraceuticals
and Brain, Neurodegenerative and Mental Disorders
Chair: M. Youdim,
USA
M. Youdim, Israel
Neuroprotective and apoptotic action
of 3, 3-epigallocatechin-3-gallate, from green tea extract
R. Reiter, USA
Melatonin as an antioxidant: Plant
sources and mechanisms of action
R. Brigelius-Flohe,
Germany
New insights into vitamin E metabolism
G. Birkmayer, Austria
Stabilized NADH (ENADAlertTM) improves
the physical and mental performance in highly conditioned athletes
V. Demarin, Croatia
ENADA/NADH improves cognitive impairment
of Alzheimer patients
G. K. Kay, USA
Stabilized NADH (ENADAlertTM) as
a
Countermeasure for Jet Lag
M. Moline, USA
Effectiveness of NADH in alleviating effects of sleep deprivation in
healthy middle-aged adults
Nutraceuticals and
Diabetes
Chair: N. Kaiser
N. Kaiser - chairman's
introduction
N. Kaiser, Israel
Nutritional Modulation of Beta-Cell
Function in the Psammomys obesus Model of Type 2 Diabetes
S. Sasson, Israel
PPARs and diabetes
M. Hadzija, Croatia
Treatment of diabetic neuropathies
V. Profozic, Croatia
Lipoate clinical trials - Neuropathics
prevention
Concluding Remarks
